These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 20302159

  • 21. [Biological therapy as treatment of inflammatory bowel diseases].
    Agnholt J.
    Ugeskr Laeger; 2008 Jun 09; 170(24):2152-6. PubMed ID: 18565302
    [Abstract] [Full Text] [Related]

  • 22. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    González Carro P, Pérez Roldán F, Roncero García Escribano O, Lafuente R, Legaz Huidobro ML, Amigo Echenagusía A.
    J Clin Apher; 2006 Dec 09; 21(4):249-51. PubMed ID: 16607627
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails?
    Lakatos PL.
    Rev Recent Clin Trials; 2009 Sep 09; 4(3):152-8. PubMed ID: 20028325
    [Abstract] [Full Text] [Related]

  • 25. Ulcerative colitis: conservative management and long-term effects.
    Kühbacher T, Schreiber S, Fölsch UR.
    Langenbecks Arch Surg; 2004 Oct 09; 389(5):350-3. PubMed ID: 15133672
    [Abstract] [Full Text] [Related]

  • 26. What is the optimal maintenance treatment for ulcerative colitis?
    Cohen RD.
    Inflamm Bowel Dis; 2008 Oct 09; 14 Suppl 2():S236-7. PubMed ID: 18816679
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.
    Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C, Bernstein CN.
    Clin Gastroenterol Hepatol; 2019 Aug 09; 17(9):1680-1713. PubMed ID: 30853616
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG, Sandborn WJ.
    Rev Gastroenterol Disord; 2002 Aug 09; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [Abstract] [Full Text] [Related]

  • 34. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC, Hanauer SB.
    Rev Gastroenterol Disord; 2004 Aug 09; 4(3):104-17. PubMed ID: 15359211
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Conventional therapy for Crohn's disease.
    Büning C, Lochs H.
    World J Gastroenterol; 2006 Aug 14; 12(30):4794-806. PubMed ID: 16937460
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Drug therapy of inflammatory bowel diseases].
    Silvennoinen J, Niemelä S.
    Duodecim; 1999 Aug 14; 115(20):2233-8. PubMed ID: 11973927
    [No Abstract] [Full Text] [Related]

  • 40. [FAQs in chronic inflammatory bowel diseases. This way your patient stays in remission].
    Stiefelhagen P.
    MMW Fortschr Med; 2011 Dec 08; 153(49-50):20-1. PubMed ID: 22308586
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.